. Mutational and structural evidence suggest that this motif
2002). RanBP2 also contains a RING domain, but it is dispensable for E3
whether CtBP was subject to SUMO modification at endogenous expression levels, HeLa cell proteins were activity, suggesting that RanBP2 represents a second class of SUMO E3s.
immunoprecipitated with an antibody specific for CtBP.
When immunoprecipitates were analyzed by SDS-PAGE We demonstrate that the transcriptional corepressor CtBP (carboxyl-terminus binding protein) is modified by
and Western blotted with a SUMO-1-specific antibody, a band of the appropriate mobility for SUMO-1-conju-SUMO-1 or SUMO-3 on a single lysine. CtBP was identified by its interaction with the adenovirus E1A protein gated CtBP was clearly visible ( Figure 1D ). This band was not detected when proteins were first immunopreand this interaction is required for transcriptional repression by E1A (Boyd et al., 1993; Schaeper et al., 1995 detected, indicating that lysine 428 is the principal lysine utilized for SUMO conjugation ( Figure 2B ). This lysine is present in the related CtBP2, but the surrounding Results motif is absent (Figure 2A ). No sumoylation of CtBP2 was detected when lysates from COS-1 cells transCtBP Is Sumoylated, In Vitro and In Vivo CtBP contains a single sumoylation motif (see Figure  fected with Fl-CtBP2, T7-Ubc9, and H6-SUMO-1 or -3 were analyzed by Western blot ( Figure 2B ). Thus, it ap-2A), suggesting that it may be a target for sumoylation. To determine whether CtBP is a potential substrate, pears that the motif surrounding lysine 428 is important for efficient sumoylation. Since lysine 428 appeared to purified bacterially expressed T7-CtBP was incubated with recombinant Aos1/Uba2 (E1), Ubc9, and SUMO-1 be the major sumoylation site in CtBP, the additional bands observed in Figure 1C are likely the result of poly in the presence of ATP. Reactions were terminated by the addition of SDS-PAGE loading buffer and analyzed sumoylation of CtBP at lysine 428. However, we cannot rule out the possibility that an initial sumoylation event by Western blot with a T7-specific antibody to detect CtBP. When recombinant E1, Ubc9, and SUMO-1 were at lysine 428 is required for subsequent modification of other lysines within CtBP. all present, a slower migrating band was observed that is consistent with the conjugation of SUMO-1 to CtBP
To determine whether either CtBP or CtBP2 was able to interact with Ubc9, COS-1 cells were transfected with ( Figure 1A ). This band was not present when either the E1, Ubc9, or SUMO-1 was absent from the reaction, expression vectors encoding Fl-CtBP, Fl-CtBP2 or FlCtBP K428R , and T7-Ubc9. Flag proteins were precipitated suggesting that CtBP can be sumoylated and indicating that CtBP minimally requires these proteins for sumofrom cell lysates and Western blotted to detect coprecipitating T7-Ubc9. Surprisingly, CtBP, CtBP2, and CtBP K428R ylation.
To determine whether CtBP can be sumoylated in all associated with Ubc9, even though only CtBP is modified by SUMO ( Figure 2C (Sewalt et al.,  1999) . We, therefore, wished to determine where in the cell sumoylated CtBP was localized. We created tagged versions of CtBP and Pc2, which were fused to colorshifted enhanced green fluorescent protein variants (either cyan or yellow; CFP or YFP). As shown in Figure  3A , when visualized by fluorescence microscopy, CFPCtBP was present in both the nucleus and cytoplasm of COS-1 cells. However, in the presence of coexpressed T7-Pc2, a significant proportion of the CFPCtBP localized to nuclear foci. Visualization of CFPCtBP and YFP-Pc2 in the same cells clearly revealed that the two proteins colocalize ( Figure 3B ). Thus, in live cells, CFP-CtBP was recruited to PcG bodies by coexpression of Pc2.
Since only a proportion of the CtBP is modified by SUMO, we first sought to determine biochemically the localization of this fraction of CtBP. Cells were treated with digitonin to selectively permeabilize the plasma membrane. After removal of the cytosol cells were treated with 1% NP40 to dissolve the nuclear membrane and release soluble nuclear proteins. The remaining insoluble cellular material was designated as the pellet fraction. Digitonin soluble, NP40 soluble, and pellet (insoluble) fractions were analyzed by Western blot with a T7 antibody to detect transfected CtBP. CtBP was primarily localized in the digitonin and NP40 soluble fractions, with some CtBP in the pellet ( Figure 3C ), consistent with its localization to nucleus and cytoplasm. When COS-1 cells were transfected with T7-CtBP, FlUbc9, and H6-SUMO-3, the majority of SUMO-3-conjugated CtBP was in the NP40 fraction, suggesting that it was present in a soluble nuclear fraction ( Figure 3C ). When Flag-Pc2 was coexpressed with T7-CtBP, FlUbc9, and H6-SUMO-3, virtually all of the SUMO-3-conjugated CtBP was present in the insoluble nuclear fraction (pellet), together with the majority of the Pc2 ( Figure  3D ). Interestingly, coexpression of Pc2 also appeared to increase the amount of SUMO-3 conjugated to CtBP. These results suggest that sumoylated CtBP is associ- ated with Pc2, and raise the possibility that Pc2 enTo further demonstrate that Pc2 is modified by SUMO, bacterially expressed T7-Pc2 was purified on T7 agahances CtBP sumoylation.
rose and incubated with GST-SUMO-3, Ubc9, E1, and ATP. As shown in Figure 4C , slower migrating forms of Pc2 Is Sumoylated Coexpression of SUMO-3 and Ubc9 with Flag-Pc2 rePc2, corresponding to attachment of multiple SUMOs to Pc2, were detected. When either SUMO-3, Ubc9, or sulted in the presence of multiple slower migrating Flagreactive bands, indicating that Pc2 may be sumoylated the E1 was absent, no modified Pc2 was observed.
Together, these results demonstrate that both CtBP and ( Figure 3D ). To test this possibility, whole cell extracts from COS-1 cells that had been transfected with T7-Pc2 are sumoylated and that sumoylated CtBP appears to be preferentially associated with Pc2. Pc2 and H6-SUMO-1 or -3 were Western blotted for T7-Pc2. In addition to detecting Pc2, multiple slower migrating bands were observed, suggesting the conjuPc2 Localizes SUMO and Ubc9 to Nuclear Foci Since Pc2 is sumoylated, we decided to use fluoresgation of multiple SUMOs to Pc2 ( Figure 4A ). The intensity of these bands was not significantly enhanced by cence microscopy to determine the effect of coexpression of Pc2 on the subcellular localization of CFPcoexpression of Ubc9, suggesting that endogenous Ubc9 levels were sufficient to sumoylate Pc2. SUMO-1. COS-1 cells transfected with CFP-SUMO-1 showed a dispersed nuclear distribution of CFPAs further evidence that the slower migrating bands were sumoylated forms of Pc2, COS-1 cells were trans-SUMO-1, with some fluorescent signal present outside the nucleus ( Figure 5A ). Coexpression of Fl-Pc2 resulted fected with T7-Pc2 and Fl-SUMO-1 or -3, and lysed in 6 M guanidine-HCl. Pc2 contains 12 consecutive histiin the localization of much of the CFP-SUMO-1 to nuclear foci characteristic of PcG bodies ( Figure 5A ). We dine residues, making it possible to purify T7-Pc2 with cobalt agarose ( Figure 4B, lower panel) . After purificaobtained similar results with CFP-SUMO-3 to those observed with SUMO-1 ( Figure 5D and data not shown). tion on cobalt agarose, proteins were Western blotted to detect Flag-SUMO conjugated to Pc2. As expected, Fluorescence microscopy of COS-1 cells transfected with YFP-Ubc9 indicated that it was localized primarily unmodified Pc2 was not detected with the Flag antibody, but multiple slower migrating forms of Pc2 were to the nucleus, and coexpression of Pc2 resulted in the recruitment of YFP-Ubc9 to nuclear foci ( Figure 5B ). To present ( Figure 4B ). In a parallel experiment, when cells were transfected with T7-Pc2 alone and proteins puriconfirm that the foci observed with YFP-Ubc9 are PcG bodies, we coexpressed YFP-Ubc9 and CFP-Pc2. As fied on cobalt agarose, conjugation of endogenous SUMO-1 to T7-Pc2 was detected ( Figure 4B, right panel) .
shown in Figure 5C , a significant proportion of both ). We, therefore, wanted to know whether Pc2 localized SUMO to nuclear dogated to CtBP and was able to further increase sumoylation over that seen with Ubc9 coexpression ( Figure 6B ). mains that were distinct from PML bodies. COS-1 cells were cotransfected with CFP-Pc2 and a YFP-PML exIn addition, when these lysates were probed for Pc2, sumoylated forms of Pc2 were detected. Interestingly, pression construct. As shown in Figure 5D , YFP-PML and CFP-Pc2 both form subnuclear foci, but do not Pc2 is a chromodomain protein, which shares no significant homology with known E3 ligases. Removal of the colocalize. In contrast, cotransfection with YFP-PML and CFP-SUMO-3 resulted in clear colocalization of chromodomain of Pc2 (construct 68-558) did not affect enhancement of CtBP sumoylation, whereas, further SUMO-3 with PML bodies. We then wanted to determine whether PML and Pc2 recruited SUMO to separate sites. truncation to amino acid 401 abolished this activity (Figure 6C) . Since both constructs interact with CtBP (data CFP-SUMO-3 localized to an increased number of foci within the nucleus of cells expressing Pc2, and only a not shown), the region between amino acids 68 and 401 may be required for Ubc9 interaction. proportion of these foci colocalized with YFP-PML (Figure 5D) To determine whether Pc2 is a SUMO E3, we perbodies. Thus, Pc2 is recruiting substrate and E2 to the of Ubc9, irrespective of Pc2 addition. We had observed that although CtBP2 interacted with Ubc9, no sumoylated CtBP2 was detected in vivo (see Figure 2) . Surprisingly, CtBP2 was sumoylated in vitro in the presence of E1 and Ubc9 and this modification was significantly enhanced by the addition of Pc2 ( Figure 7B ). We next determined whether Pc2 expression would allow detection of CtBP2 sumoylation in vivo, by enhancing the level of this modification. As shown in Figure 7C , coexpression of H6-SUMO-1 with either Ubc9 or Pc2 resulted in efficient sumoylation of CtBP, but not of the CtBP K428R mutant. Interestingly, although no sumoylated CtBP2 was observed in the presence of H6-SUMO-1 and Ubc9, the coexpression of Pc2 and H6-SUMO-1 clearly induced CtBP2 sumoylation ( Figure 7C ). Taken together, these results demonstrate that Pc2 is a SUMO E3.
Discussion
We show that CtBP can be sumoylated, both in vivo and in vitro, at a SUMO consensus motif. Importantly, Pc2 clearly enhances sumoylation of CtBP, suggesting that Pc2 represents a novel class of SUMO E3s. In addition, Pc2 can recruit both CtBP and Ubc9 to PcG bodies, suggesting that these structures may function as centers of sumoylation within the nucleus.
A SUMO E3
Ubc9 is necessary and sufficient to attach SUMO to numerous substrates. However, by analogy with ubiquitination, SUMO E3s are likely to help determine substrate specificity and enhance efficiency of sumoylation. Ubiquitin E3s fall into two classes: HECT domain proteins are true enzymes, which form a thioester bond with ubiquitin prior to transferring it to the substrate. In contrast, RING domain proteins act as adapters, bringing together E2 and substrate (Laney and Hochstrasser, 1999). Two classes of SUMO E3 have been identified, both of which contain RING-like domains and appear to act as nonenzymatic adapters. In Siz1p and PIAS proteins, the RING-like domains are required for E3 activity ( recruits other proteins to PcG bodies to be sumoylated. absence of a targeting motif, a SUMO E3 can determine substrate specificity. Thus, it appears that two factors It is also possible that other PcG proteins may be part of a Pc2-containing E3 complex. It will now be of interest can contribute to substrate specificity: The presence of a sumoylation motif within the substrate, and the to determine the importance of other PcG proteins for sumoylation of CtBP or other substrates.
presence of an appropriate E3 factor. That Pc2 can enhance sumoylation of CtBP2 by Ubc9, suggests that Our data demonstrate that Pc2 represents a novel class of SUMO E3, which has no obvious sequence other potential SUMO substrates, which lack the targeting motif may indeed be sumoylated in vivo, provided similarity to other known E3s, perhaps suggesting the existence of other unrelated SUMO E3s. It is likely that the correct E3 is present. multiple E3s will compete for interaction with Ubc9 and recruit it to specific subcellular locations, resulting in A Novel Function for Polycomb Bodies a high local concentration of E2 and substrate. Thus, We have demonstrated a novel enzymatic activity at proteins like Pc2 may be important rate-limiting factors PcG complexes, which results in the sumoylation of at in specific sumoylation pathways. least two proteins. Although purified recombinant Pc2 has E3 activity toward CtBP, it is possible that, since Pc2 is part of a multimeric complex, other associated Nonconsensus SUMO Substrates Many SUMO substrates, including CtBP, contain a conPcG proteins may contribute to full E3 activity in vivo. Pc2 recruits Ubc9 and SUMO, resulting in Pc2 sumoylasensus targeting motif, which is clearly an important determinant of substrate specificity. We show that tion. This E2-E3 complex (Ubc9 and Pc2) efficiently sumoylates CtBP, and may also modify other PcG proteins CtBP2, which does not contain this motif, interacts with Ubc9 and is sumoylated in vitro. However, in vivo suwithin the complex. For example, Bmi-1 contains a SUMO consensus site, is a component of PcG commoylation of CtBP2 is much more dependent on Pc2 than is sumoylation of CtBP, suggesting that even in the plexes, and Bmi-1 interacts with Pc2 (Gunster et al., complex. These may then be sumoylated by Pc2-associBacterial histidine tagged CtBP2 was expressed from pParallel. A Pc2 construct was engineered by PCR which lacked the internal ated Ubc9.
poly-histidine stretch (aa 381-399) and was truncated at codon 529, and was expressed from within pParallel. 
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